Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic Leukemia

Chimeric antigen T-cell (CAR T) therapy is a promising emerging treatment option for patients with relapsed/refractory acute lymphoma. The role of bridging radiotherapy prior to CAR T infusion is an area of increasing interest with a sizable body of literature regarding its use in non-Hodgkin lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladbury, Colton, Salhotra, Amandeep, Dandapani, Savita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723713/
https://www.ncbi.nlm.nih.gov/pubmed/35003969
http://dx.doi.org/10.7759/cureus.20134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723713/
https://www.ncbi.nlm.nih.gov/pubmed/35003969
http://dx.doi.org/10.7759/cureus.20134

Ejemplares similares